Limitations of this work include use of a single model of cystic kidney disease, global (non‐targeted) deletion of the Spp1 gene, no investigation of phenotypic changes in kidney macrophage subpopulations, and lack of a definitive explanation as to how OPN deletion could reduce cyst burden while exacerbating kidney fibrosis in this model. The gene discussed is SPP1; the disease is cyst.